| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30006157 | HIV | ENSG00000139626.16 | protein_coding | ITGB7 | No | No | 3695 | P26010 |
| TVIS30011730 | HIV | ENSG00000139626.16 | protein_coding | ITGB7 | No | No | 3695 | P26010 |
| TVIS30021227 | HIV | ENSG00000139626.16 | protein_coding | ITGB7 | No | No | 3695 | P26010 |
| TVIS20020554 | HPV | ENSG00000139626.16 | protein_coding | ITGB7 | No | No | 3695 | P26010 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | ITGB7 |
|---|---|
| DrugBank ID | DB09033 |
| Drug Name | Vedolizumab |
| Target ID | BE0003414 |
| UniProt ID | P26010 |
| Regulation Type | antibody |
| PubMed IDs | 19509315 |
| Citations | Soler D, Chapman T, Yang LL, Wyant T, Egan R, Fedyk ER: The binding specificity and selective antagonism of vedolizumab, an anti-alpha4beta7 integrin therapeutic antibody in development for inflammatory bowel diseases. J Pharmacol Exp Ther. 2009 Sep;330(3):864-75. doi: 10.1124/jpet.109.153973. Epub 2009 Jun 9. |
| Groups | Approved |
| Direct Classification | Peptides |
| SMILES | |
| Pathways | |
| PharmGKB | |
| ChEMBL | CHEMBL1743087 |
